Toneman Masja K, de Kok Bente M, Zijta Frank M, Oei Stanley, van Acker Gijs J D, Westerterp Marinke, van der Pool Anne E M
Department of Surgery, Haaglanden Medical Centre, The Hague 2512 VA, Netherlands.
Department of Radiology, Haaglanden Medical Centre, The Hague 2512 VA, Netherlands.
World J Gastrointest Surg. 2022 Jun 27;14(6):556-566. doi: 10.4240/wjgs.v14.i6.556.
Closed-loop small bowel obstruction (CL-SBO) can threaten the viability of the intestine by obstructing a bowel segment at two adjacent points. Prompt recognition and surgery are crucial.
To analyze the outcomes of patients who underwent surgery for CL-SBO and to evaluate clinical predictors.
Patients who underwent surgery for suspected CL-BSO on computed tomography (CT) at a single center between 2013 and 2019 were evaluated retrospectively. Patients were divided into three groups by perioperative outcome, including viable bowel, reversible ischemia, and irreversible ischemia. Clinical and laboratorial variables at presentation were compared and postoperative outcomes were analyzed.
Of 148 patients with CL-SBO, 28 (19%) had a perioperative viable small bowel, 86 (58%) had reversible ischemia, and 34 (23%) had irreversible ischemia. Patients with a higher age had higher risk for perioperative irreversible ischemia [odds ratio (OR): 1.03, 95% confidence interval (CI): 0.99-1.06]. Patients with American Society of Anaesthesiologists (ASA) classification ≥ 3 had higher risk of perioperative irreversible ischemia compared to lower ASA classifications (OR: 3.76, 95%CI: 1.31-10.81). Eighty-six patients (58%) did not have elevated C-reactive protein (> 10 mg/L), and between-group differences were insignificant. Postoperative in-hospital stay was significantly longer for patients with irreversible ischemia (median 8 d, = 0.001) than for those with reversible ischemia (median 6 d) or a viable bowel (median 5 d). Postoperative morbidity was significantly higher in patients with perioperative irreversible ischemia (45%, = 0.043) compared with reversible ischemia (20%) and viable bowel (4%).
Older patients or those with higher ASA classification had an increased risk of irreversible ischemia in case of CL-SBO. After irreversible ischemia, postoperative morbidity was increased.
闭环性小肠梗阻(CL-SBO)可通过在两个相邻点阻塞肠段来威胁肠的生存能力。及时识别和手术至关重要。
分析接受CL-SBO手术患者的结局并评估临床预测因素。
对2013年至2019年在单一中心因疑似CL-BSO接受计算机断层扫描(CT)检查并接受手术的患者进行回顾性评估。根据围手术期结局将患者分为三组,包括存活肠段、可逆性缺血和不可逆性缺血。比较就诊时的临床和实验室变量并分析术后结局。
148例CL-SBO患者中,28例(19%)围手术期小肠存活,86例(58%)有可逆性缺血,34例(23%)有不可逆性缺血。年龄较大的患者围手术期发生不可逆性缺血的风险较高[比值比(OR):1.03,95%置信区间(CI):0.99-1.06]。与美国麻醉医师协会(ASA)分级较低的患者相比,ASA分级≥3的患者围手术期发生不可逆性缺血的风险更高(OR:3.76,95%CI:1.31-10.81)。86例患者(58%)的C反应蛋白未升高(>10mg/L),组间差异不显著。不可逆性缺血患者的术后住院时间(中位数8天,=0.001)明显长于可逆性缺血患者(中位数6天)或存活肠段患者(中位数5天)。围手术期发生不可逆性缺血的患者术后发病率(45%,=0.043)明显高于可逆性缺血患者(20%)和存活肠段患者(4%)。
年龄较大的患者或ASA分级较高的患者在CL-SBO时发生不可逆性缺血的风险增加。发生不可逆性缺血后,术后发病率增加。